Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without diabetes. 25-hydroxyvitamin D level (normal range of values is 25 to 125 nmol/L) was measured following an overnight fasting.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without diabetes.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study

Cross-sectional study · Journal of Nephropharmacology · 2012

Original publication title

Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study

Hamid Nasri; Mahmoud Rafieian-Kopaei

© 2012 The Author(s)

Original publication · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In summary, we concluded that our findings are of interest for two reasons: first, because there is limited previous data concerning low serum 25-hydroxyvitamin D in diabetics in comparison to non-diabetic patients. However further investigations are needed to define this aspect of hemodialysis patients.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

25-hydroxyvitamin D is the main circulating metabolite of vitamin D (1). It is well found that the assessment of circulating 25-hydroxyvitamin D offers better information vitamin D status in patients, while biological active form of vitamin D is 1,25(OH)2 vitamin D, synthesized in the kidney. Recently, various investigations have highlighted the role of plasma 25-hydroxyvitamin D level in mineral metabolism dysregulation in chronic renal failure (1,2). It has been established that a moderate reduction in plasma 25-hydroxyvitamin D level plays a role in the development of secondary form of hyperparathyroidism in patients under hemodialysis, while a greater reduction in plasma 25-hydroxyvitamin D level is associated with the risk of getting osteoporosis (1Not reported3).

Moreover, less attention has been made to 25-hydroxyvitamin D in hemodialysis patients with or without diabetes. This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis patients with or without diabetes.

Source: Introduction

Study methods

What methods does the paper describe?

Patients

This cross-sectional study was carried out on a group of stable hemodialysis patients. According to the intensity of secondary hyperparathyroidism, each patient received oral active vitamin D3 (Calcitriol; Rocaltrol), calcium carbonate or Rena-Gel (Sevelamer) tablets at various doses.

The study was done in the hemodialysis (HD) section of Hajar Medical Educational and Therapeutic Center of Shahrekord University of Medical Sciences in Shahrekord, Iran.

Laboratory methods

25-hydroxyvitamin D level (normal range of values is 25 to 125 nmol/L) was measured following an overnight fasting, by enzyme-linked immunosorbent assay (ELISA) method with DRG kits from Germany. Also serum pre-dialysis and post dialysis blood urea nitrogen (BUN) was measured. For the efficacy of HD, the urea reduction rate (URR) was calculated from pre: and post-blood urea nitrogen (BUN) data. Duration and proportion of hemodialysis were assessed from the patients’ records. The duration of each HD session was 4 hours.

Ethical issues

The research followed the tenets of the declaration of Helsinki; written informed consent was obtained and the research was approved by ethical committee of Shahrekord University of Medical Sciences.

Statistical analysis

Data were expressed as the mean±SD and median values. The comparison between the groups was done using the student’s t-test. The statistical analyses were performed using SPSS 11.5 (SPSS Inc., Chicago, USA)). The statistical significance was determined at a p<0.05.

Source: Patients and Methods Source: Patients and Methods Source: Patients and Methods Source: Patients and Methods

Implication for health policy/practice/research/medical education

In a study on 36 stable hemodialysis patients, we found a low serum 25-hydroxyvitamin D in diabetic male patients in comparison to non-diabetic males. Further investigations need to define this aspect of hemodialysis patients.

Source: Implication for health policy/practice/research/medical education:

Discussion

In this study we found a significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic subjects of male HD patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found. Gonzalez et al. conducted a study on 103 patients undergoing HD and found that 97% of the patients had vitamin D levels in the suboptimal range (4). In a study on 230 patients, Wang et al. found that a lower serum 25-hydroxyvitamin D level was associated with an increased risk of cardiovascular events in routine peritoneal dialysis patients (5).

Limited studies have conducted on the impact of diabetes on 25-hydroxyvitamin D level in HD patients. Lower vitamin D level in diabetic patients may aggravate their conditions.

Source: Discussion

Authors’ Contributions

HN and MRK wrote the manuscript equally.

Source: Authors’ Contributions

Ethical considerations

Ethical issues (including plagiarism, data fabrication, double publication) have been completely considered by the authors.

Source: Ethical considerations

Funding/Support

Results

The study was conducted on 36 (female 15, male 21), consisting of 25 (F=11, M=14) non-diabetic HD patients and 11 (F=4, M=7) diabetic HD patients. Table 1 summarizes some data of the patients. The mean patients’ age was 47±17 years. The mean value of serum 25-hydroxyvitamin D level of patients was 10.5±18.7 nmol/L. There were no significant differences of serum 25-hydroxyvitamin D level between male and female subjects or diabetic and non-diabetic patients (p; N.S). A significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic subjects of male HD patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found (r=0.014).

Table 1

Data of hemodialysis patients

Total patients N=36 Mean ±SD Median
Age (years)47±1743
DH* (months)32±3619
Dialysis proportion123±54156
URR (%)59±957.5
25-OH vit. D (nmol/l)10.5±18.73.5

*Duration of hemodialysis

Source: Results Source: Results

Conclusion

In summary, we concluded that our findings are of interest for two reasons: first, because there is limited previous data concerning low serum 25-hydroxyvitamin D in diabetics in comparison to non-diabetic patients. However further investigations are needed to define this aspect of hemodialysis patients.

Source: Conclusion
Authors’ abstract

It is well found that the assessment of circulating 25-hydroxyvitamin D offers better information about vitamin D status in patients. This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without diabetes. 25-hydroxyvitamin D level (normal range of values is 25 to 125 nmol/L) was measured following an overnight fasting. The study was conducted on 36 subjects (15 female, 21 male), consisting of 25 (female=11, male=14) non-diabetic HD patients and 11 (female=4, male=7) diabetic HD patients.

A significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic male HD patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found (r=0.014). Least studied was conducted on the influence of diabetes on 25-hydroxyvitamin D level in HD patients, lower vitamin D level in diabetes patients may aggravates their condition. Thus, further investigations need to define this aspect of hemodialysis patients.

Read the full paper

Implication for health policy/practice/research/medical education:

In a study on 36 stable hemodialysis patients, we found a low serum 25-hydroxyvitamin D in diabetic male patients in comparison to non-diabetic males. Further investigations need to define this aspect of hemodialysis patients.

Introduction

25-hydroxyvitamin D is the main circulating metabolite of vitamin D (1). It is well found that the assessment of circulating 25-hydroxyvitamin D offers better information vitamin D status in patients, while biological active form of vitamin D is 1,25(OH)2 vitamin D, synthesized in the kidney. Recently, various investigations have highlighted the role of plasma 25-hydroxyvitamin D level in mineral metabolism dysregulation in chronic renal failure (1,2). It has been established that a moderate reduction in plasma 25-hydroxyvitamin D level plays a role in the development of secondary form of hyperparathyroidism in patients under hemodialysis, while a greater reduction in plasma 25-hydroxyvitamin D level is associated with the risk of getting osteoporosis (1Not reported3).

Moreover, less attention has been made to 25-hydroxyvitamin D in hemodialysis patients with or without diabetes. This cross-sectional study was aimed to better understand the probable difference of 25-hydroxyvitamin D level in a group of hemodialysis patients with or without diabetes.

Patients and Methods

Patients

This cross-sectional study was carried out on a group of stable hemodialysis patients. According to the intensity of secondary hyperparathyroidism, each patient received oral active vitamin D3 (Calcitriol; Rocaltrol), calcium carbonate or Rena-Gel (Sevelamer) tablets at various doses.

The study was done in the hemodialysis (HD) section of Hajar Medical Educational and Therapeutic Center of Shahrekord University of Medical Sciences in Shahrekord, Iran.

Laboratory methods

25-hydroxyvitamin D level (normal range of values is 25 to 125 nmol/L) was measured following an overnight fasting, by enzyme-linked immunosorbent assay (ELISA) method with DRG kits from Germany. Also serum pre-dialysis and post dialysis blood urea nitrogen (BUN) was measured. For the efficacy of HD, the urea reduction rate (URR) was calculated from pre: and post-blood urea nitrogen (BUN) data. Duration and proportion of hemodialysis were assessed from the patients’ records. The duration of each HD session was 4 hours.

Ethical issues

The research followed the tenets of the declaration of Helsinki; written informed consent was obtained and the research was approved by ethical committee of Shahrekord University of Medical Sciences.

Statistical analysis

Data were expressed as the mean±SD and median values. The comparison between the groups was done using the student’s t-test. The statistical analyses were performed using SPSS 11.5 (SPSS Inc., Chicago, USA)). The statistical significance was determined at a p<0.05.

Results

The study was conducted on 36 (female 15, male 21), consisting of 25 (F=11, M=14) non-diabetic HD patients and 11 (F=4, M=7) diabetic HD patients. Table 1 summarizes some data of the patients. The mean patients’ age was 47±17 years. The mean value of serum 25-hydroxyvitamin D level of patients was 10.5±18.7 nmol/L. There were no significant differences of serum 25-hydroxyvitamin D level between male and female subjects or diabetic and non-diabetic patients (p; N.S). A significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic subjects of male HD patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found (r=0.014).

Table 1

Data of hemodialysis patients

Total patients N=36 Mean ±SD Median
Age (years)47±1743
DH* (months)32±3619
Dialysis proportion123±54156
URR (%)59±957.5
25-OH vit. D (nmol/l)10.5±18.73.5

*Duration of hemodialysis

Discussion

In this study we found a significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic subjects of male HD patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found. Gonzalez et al. conducted a study on 103 patients undergoing HD and found that 97% of the patients had vitamin D levels in the suboptimal range (4). In a study on 230 patients, Wang et al. found that a lower serum 25-hydroxyvitamin D level was associated with an increased risk of cardiovascular events in routine peritoneal dialysis patients (5).

Limited studies have conducted on the impact of diabetes on 25-hydroxyvitamin D level in HD patients. Lower vitamin D level in diabetic patients may aggravate their conditions.

Conclusion

In summary, we concluded that our findings are of interest for two reasons: first, because there is limited previous data concerning low serum 25-hydroxyvitamin D in diabetics in comparison to non-diabetic patients. However further investigations are needed to define this aspect of hemodialysis patients.

Authors’ Contributions

HN and MRK wrote the manuscript equally.

Conflict of interests

The authors declared no competing interests.

Ethical considerations

Ethical issues (including plagiarism, data fabrication, double publication) have been completely considered by the authors.

Funding/Support

None.

References

1 Hollis BW Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it Calcif Tissue Int 1996 58 4 5 8825231 10.1007/BF02509538
2 Thomas MK Lloyd-Jones DM Thadhani RI Shaw AC Deraska DJ Kitch BT Hypovitaminosis D in medical inpatients N Engl J Med 1998 338 777 83 9504937 10.1056/NEJM199803193381201
3 Locatelli F Cannata-Andía JB Drüeke TB Hörl WH Fouque D Heimburger O Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia Nephrol Dial Transplant 2002 17 723 31 11981055 10.1093/ndt/17.5.723
4 Gonzalez EA Sachdeva A Oliver DA Martin KJ Vitamin D insufficiency and deficiency in chronic kidney disease A single center observational study Am J Nephrol 2004 24 503 10 15452403 10.1159/000081023
5 Wang AY Lam CW Sanderson JE Wang M Chan IH Lui SF Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study Am J Clin Nutr 2008 87 1631 8 18541550 10.1093/ajcn/87.6.1631
Publication and source details

Original title: Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with or without diabetes; a single center study

Hamid Nasri; Mahmoud Rafieian-Kopaei

Journal of Nephropharmacology · 2012

* Corresponding author: Prof. Mahmoud Rafieian-kopaei, Medical Plants Research Center, Shahrekord University of Medical Sciences, Sharekord, Iran. rafieian@yahoo.com© 2012 The Author(s)2012https://creativecommons.org/licenses/by/4.0/ Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:32:44.591113+00:00

DOI: · PMC5297577